insights_auto
Outlook: 66.2% bullish·2.9% bearish
Pumunta sa pagsusurichevron_right
LLY:NYSE
Eli Lilly And Co
$1,142.85
arrow_downward
-0.61%(-7.00) 1D
$1,141.93
arrow_downward
-0.08% (-0.92)todayPre-market
Sarado: Okt 2, 4:00:05 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa LLY...
Buksan
$1,153.82
Mataas
$1,164.92
Mababa
$1,136.66
Mkt. cap
1.08T
Avg. na dami
2.36M
Dami
2.27K
Dividend
0.61%
Bawat tatlong buwang dividend
$1.73
Petsa ng ex-dividend
Ago 14, 2026
P/E ratio
38.36
Mataas nang 52-wk
$1,292.65
Mababa nang 52-wk
$783.85
EPS
$29.80
Beta
0.46
Mga natitirang share
941.36M
Bilang ng mga empleyado
50K
Buksan
$1,153.82
Mataas
$1,164.92
Mababa
$1,136.66
Mkt. cap
1.08T
Avg. na dami
2.36M
Dami
2.27K
Dividend
0.61%
Bawat tatlong buwang dividend
$1.73
Petsa ng ex-dividend
Ago 14, 2026
P/E ratio
38.36
Mataas nang 52-wk
$1,292.65
Mababa nang 52-wk
$783.85
EPS
$29.80
Beta
0.46
Mga natitirang share
941.36M
Bilang ng mga empleyado
50K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Stock Titan
·
10 minuto ang nakalipas
Lilly will present teen eczema data on treatment doses spaced eight weeks apart
Barchart.com
·
30 minuto ang nakalipas
NVO vs. LLY: Novo’s CEO Says Confidence Is Gone. Lilly Is Winning 7 in 10 New Seniors.
marketscreener.com
·
47 minuto ang nakalipas
TRex Bio to Sell 8.33 Million Shares at $14-$16 Each in IPO
AD HOC NEWS
·
1 oras ang nakalipas
Eli Lilly reports Foundayo data and Berenberg rates Eli Lilly stock Buy
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Tungkol sa Eli Lilly And Co
CEODavid A. Ricks
Mga Empleyado50K
Itinatag1876
HeadquartersIndianapolis, Indiyana, Estados Unidos
Sektor-
Websitelilly.com